Dividend ETF Showdown: Schwab U.S. Dividend Equity vs. Vanguard Dividend Appreciation

Dividend ETF Showdown: Schwab U.S. Dividend Equity vs. Vanguard Dividend Appreciation

Key Points

• Schwab U.S. Dividend Equity ETF offers a significantly higher trailing-12-month dividend yield than Vanguard Dividend Appreciation ETF.

• Vanguard’s fund leans heavily into technology, while Schwab’s ETF prioritizes healthcare and consumer defensives.

• SCHD showed stronger one-year total returns and lower historical price volatility as measured by beta.

The Schwab U.S. Dividend Equity ETF (NYSEMKT:SCHD) offers a higher current yield and deeper value tilt, whereas the Vanguard Dividend Appreciation ETF (NYSEMKT:VIG) focuses on consistent dividend growth and tech-heavy quality.

Both funds target dividend-paying companies, but their underlying methodologies lead to distinct portfolio profiles. The Schwab fund screens for sustainable high yields and fundamental financial strength, while the Vanguard fund strictly requires a 10-year track record of annual dividend increases. This difference creates a more conservative, tech-forward tilt for the Vanguard fund versus the value focus of its peer.

Snapshot (cost & size)

Metric	VIG	SCHD
Issuer	Vanguard	Schwab
Share price (as of Aug. 27, 2026)	$243.23	$34.83
Expense ratio	0.04%	0.06%
1-year return (as of Aug. 27, 2026)	17.1%	29.5%
Dividend yield	1.5%	3%
Beta	0.81	0.68
AUM	$130.9 billion	$111.7 billion

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Performance & risk comparison

Metric	VIG	SCHD
Max drawdown (5 year)	(20.4%)	(16.8%)
Growth of $1,000 over 5 years (total return)	$1,643	$1,607

What’s inside

The Schwab U.S. Dividend Equity ETF aims to track the overall performance of the Dow Jones U.S. Dividend 100 Index, which filters for companies with high yields and consistent payment histories. This investment strategy results in a portfolio of 102 holdings that concentrates on healthcare at 21%, consumer defensive at 20%, and energy at 15%. Its largest positions include Merck (NYSE:MRK) at 4.92%, Abbott Laboratories (NYSE:ABT) at 4.83%, and Amgen (NASDAQ:AMGN) at 4.8%. Launched in 2011, SCHD has paid $1.05 per share over the trailing 12 months.

The Vanguard Dividend Appreciation ETF seeks to track the S&P U.S. Dividend Growers Index by focusing on companies that have increased their annual payouts for at least 10 consecutive years. This methodology results in a 333-holding portfolio led by technology at 26%, financial services at 22%, and healthcare at 18%. Top holdings include Broadcom (NASDAQ:AVGO) at 4.63%, Apple (NASDAQ:AAPL) at 4.45%, and Microsoft (NASDAQ:MSFT) at 4.34%. Launched in 2006, VIG has paid $3.58 per share over the trailing 12 months.

Which looks like the better buy?

Both of these ETFs are highly appealing to income investors. While SCHD carries a slightly higher expense ratio, a 2-basis-point difference is negligible. Their assets under management are comparable, with VIG being slightly larger. However, SCHD boasts much higher average trading volume, suggesting greater liquidity. Although Vanguard’s one-year return trails Schwab’s, the ETFs are closely matched when evaluating five-year returns.

The two primary differentiators are portfolio composition and yield. VIG holds over 300 stocks, while SCHD has roughly 100. Neither ETF has a position exceeding a 5% weighting, which is generally attractive from a risk perspective. VIG appears more diversified on the surface, but its top three holdings are multitrillion-dollar technology companies, introducing some concentration risk.

Finally, the yield: Schwab’s fund pays out nearly twice as much as Vanguard’s does. All else equal, SCHD’s value orientation and higher yield make it the more attractive buy.

Source link